Mixed acinar-endocrine carcinoma of the pancreas. A clinicopathological study and comparison with acinar-cell carcinoma
- PMID: 15517367
- DOI: 10.1007/s00428-004-1037-x
Mixed acinar-endocrine carcinoma of the pancreas. A clinicopathological study and comparison with acinar-cell carcinoma
Abstract
We compared the clinicopathological features of acinar-cell carcinomas (ACCs) with those of mixed acinar-endocrine carcinomas (MAECs). Specimens from 37 patients with ACC and 6 patients with MAEC were examined histologically and immunohistochemically. The mean age of ACC and MAEC patients was similar (61.3 years versus 58.4 years), but the sex ratio differed (ACC, 29 males and 8 females; MAEC, 2 males and 4 females). The size of the tumor was large in both cases (ACC, 13.8 cm in diameter; MAEC, 8.2 cm). Immunohistochemically, more than half of the tumor cells in all tumors, whether ACC or MAEC, stained for trypsin. In 20 of the 37 ACCs (54%), scattered endocrine cells (SECs) were found, which stained positively for synaptophysin (SYN) and/or chromogranin A (CGA). Interestingly, there was also a difference in the sex ratio between ACC patients without SECs (16 males and 1 female) and ACC patients with SECs (13 males and 7 females). In MAECs, the cells staining for SYN were more common than those staining for CGA and made up more than one-third of the neoplastic-cell population. In all but one case (in which the endocrine component was arranged in islet-like cell clusters), the endocrine cells were intimately mixed with trypsin-positive tumor cells. The endocrine cells only rarely expressed one of the known pancreatic or gastrointestinal hormones. Both ACCs and MAECs had a high proliferation rate and lacked p53 overexpression or progesterone and estrogen receptors. This study revealed that ACCS and MAECs share most clinicopathological features and, therefore, may form a single tumor entity, though they differ in the number of endocrine cells. The frequent identification of endocrine cells in these tumors suggests the existence of a pluripotent cell of origin that is capable of differentiating into acinar and endocrine cells.
Similar articles
-
Immunohistochemistry in the differential diagnosis of acinar and endocrine pancreatic neoplasms.Appl Immunohistochem Mol Morphol. 2000 Sep;8(3):203-9. doi: 10.1097/00129039-200009000-00006. Appl Immunohistochem Mol Morphol. 2000. PMID: 10981872
-
Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.Am J Surg Pathol. 2010 Apr;34(4):510-8. doi: 10.1097/PAS.0b013e3181cfcac7. Am J Surg Pathol. 2010. PMID: 20182344
-
Mixed acinar-neuroendocrine carcinoma of the pancreas: a case report and a review.Histol Histopathol. 2016 Dec;31(12):1381-8. doi: 10.14670/HH-11-767. Epub 2016 Apr 15. Histol Histopathol. 2016. PMID: 27081013 Review.
-
The cytologic and immunohistochemical findings of pancreatic mixed acinar-endocrine carcinoma.Diagn Cytopathol. 2021 Feb;49(2):287-294. doi: 10.1002/dc.24641. Epub 2020 Oct 31. Diagn Cytopathol. 2021. PMID: 33128511
-
Acinar cell carcinoma of the pancreas.Ultrastruct Pathol. 2000 Jul-Aug;24(4):227-41. doi: 10.1080/01913120050176680. Ultrastruct Pathol. 2000. PMID: 11013963 Review.
Cited by
-
Acinar cell carcinoma of the pancreas: an institutional series of resected patients and review of the current literature.J Gastrointest Surg. 2008 Jun;12(6):1061-7. doi: 10.1007/s11605-007-0338-1. Epub 2007 Oct 24. J Gastrointest Surg. 2008. PMID: 17957440
-
A resected case of acinar cell carcinoma of the pancreas with liver metastasis following chemotherapy using modified FOLFIRINOX.Surg Case Rep. 2023 Aug 23;9(1):147. doi: 10.1186/s40792-023-01729-1. Surg Case Rep. 2023. PMID: 37610633 Free PMC article.
-
A narrative review on rare types of pancreatic cancer: should they be treated as pancreatic ductal adenocarcinomas?Ther Adv Med Oncol. 2024 Jul 26;16:17588359241265213. doi: 10.1177/17588359241265213. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39072242 Free PMC article. Review.
-
Mixed acinar-endocrine carcinoma of the pancreas treated with S-1.Clin J Gastroenterol. 2013 Dec;6(6):459-64. doi: 10.1007/s12328-013-0416-8. Epub 2013 Sep 5. Clin J Gastroenterol. 2013. PMID: 26182137
-
Mixed acinar-endocrine carcinoma of the pancreas with intraductal growth into the main pancreatic duct: Report of a case.Surg Today. 2010 Apr;40(4):380-4. doi: 10.1007/s00595-009-4083-9. Epub 2010 Mar 26. Surg Today. 2010. PMID: 20339996
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous